Paychex director awarded 725 RSUs, 3,061 options at $127.52

Paychex Inc. (PAYX) director reported equity awards.

Rhea-AI Filing Summary

Paychex Inc. (PAYX) director reported equity awards. On 10/15/2025, the insider acquired 725 shares of common stock at $0, described as an award of restricted stock units subject to vesting. Following this, the insider beneficially owned 8,254 shares directly. The filing also shows a new stock option grant for 3,061 shares at an exercise price of $127.52, first exercisable on 10/15/2026 and expiring on 10/14/2035, alongside previously granted options with various terms.

Insights

Equity compensation analyst

Routine director equity awards; neutral impact.

Paychex reported a director’s grant of 725 restricted stock units (price $0) and a new stock option for 3,061 shares at $127.52. RSUs vest per plan terms, while the option becomes exercisable on 10/15/2026 and expires on 10/14/2035.

These are standard compensation actions that do not change operations or guidance. The insider’s directly owned common shares totaled 8,254 after the RSU entry. Actual dilution, if any, depends on future vesting and option exercise decisions.

Insider Trade Summary

Grant/Award: 3,786 shares

Grant/Award 11 txns

Insider WILSON KARA

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option	3,061	$127.52	$390K
Grant/Award	Common Stock	725	$0.00	$0.00
holding	Stock Option	--	--	--
holding	Stock Option	--	--	--
holding	Stock Option	--	--	--
holding	Stock Option	--	--	--
holding	Stock Option	--	--	--
holding	Stock Option	--	--	--
holding	Stock Option	--	--	--
holding	Stock Option	--	--	--
holding	Stock Option	--	--	--

Holdings After Transaction: Stock Option — 50,544 contracts for 47,483 underlying shares (Direct); Common Stock — 8,254 shares (Direct)

Footnotes (1)

1. F1. Award of restricted stock units, subject to vesting, pursuant to the Amended and Restated 2002 Stock Incentive Plan.

FAQ

What equity awards were reported for PAYX on this Form 4?

A grant of 725 restricted stock units at $0 and a new stock option for 3,061 shares at an exercise price of $127.52.

How many PAYX shares did the insider own after the reported transaction?

The insider beneficially owned 8,254 shares directly following the reported RSU award.

When do the newly granted PAYX options become exercisable and when do they expire?

The options first become exercisable on 10/15/2026 and expire on 10/14/2035.

What is the exercise price of the new PAYX stock option grant?

The exercise price is $127.52 per share.

What was the transaction date for the PAYX insider awards?

The transaction date was 10/15/2025.

What explains the $0 price on the 725-share PAYX entry?

It is an award of restricted stock units subject to vesting under the company’s stock incentive plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 10/17/2025 - 04:00 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

WILSON KARA

(Last) (First) (Middle)

911 PANORAMA TRAIL SOUTH

(Street)

ROCHESTER NY 14625

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
PAYCHEX INC [ PAYX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
10/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/15/2025		A		725(1)	A	$0	8,254	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option	$127.52	10/15/2025		A		3,061		10/15/2026	10/14/2035	Common Stock	3,061	$127.52	3,061	D
Stock Option	$57.2							07/13/2018	07/12/2027	Common Stock	9,615		9,615	D
Stock Option	$70.37							07/12/2019	07/11/2028	Common Stock	8,641		8,641	D
Stock Option	$85.33							07/11/2020	07/10/2029	Common Stock	7,929		7,929	D
Stock Option	$73.53							07/15/2021	07/14/2030	Common Stock	5,793		5,793	D
Stock Option	$112.67							07/15/2022	07/14/2031	Common Stock	5,075		5,075	D
Stock Option	$115							07/15/2023	07/14/2032	Common Stock	3,027		3,027	D
Stock Option	$120.86							07/15/2024	07/14/2033	Common Stock	3,382		3,382	D
Stock Option	$121.63							07/15/2025	07/14/2034	Common Stock	3,351		3,351	D
Stock Option	$140.68							07/15/2026	07/14/2035	Common Stock	670		670	D

Explanation of Responses:

1. Award of restricted stock units, subject to vesting, pursuant to the Amended and Restated 2002 Stock Incentive Plan.

	Prabha S. Bhandari, Attorney-in-fact	10/17/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.